LPN in Patients With High-complex Renal Tumors
- Conditions
- Renal CancerRenal Cell CarcinomaSurgeryOncologyKidney InjuryUrologic CancerKidney IschemiaRenal NeoplasmUrologic NeoplasmsKidney Neoplasms
- Interventions
- Procedure: laparoscopic partial nephrectomyProcedure: Laparoscopic radical nephrectomy
- Registration Number
- NCT04933604
- Lead Sponsor
- Samsun Liv Hospital
- Brief Summary
The study aims to investigate the rationale for LPN in patients with high-complexity renal tumors in terms of oncologic and functional outcomes.
- Detailed Description
From November 2009 to October 2018, 399 patients underwent LPN and 307 patients to laparoscopic radical nephrectomy (LRN). 41 patients with RENAL score ≥ 10 enrolled in LPN and 265 patients to the LRN group. Propensity score matching (matched by age, gender, clinical tumor stage, tumor size, baseline renal function, comorbidities such as diabetes mellitus (DM), hypertension (HT), coronary artery disease (CAD), and final tumor pathology of RCC) was used to reduce selection bias. Functional and oncological outcomes were compared between the two groups. After propensity score analysis, 39 patients in the LRN group were matched with 39 in the LPN group.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
- Patients with complete data
- Patients with single renal tumor on the effected side
- Patients who approved the written consent form
- Patients who not approved the written consent form
- Patients with incomplete data
- Patients with low or mild complexity renal tumors
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description LPN group laparoscopic partial nephrectomy 39 patients with high complexity renal tumors who underwent laparoscopic partial nephrectomy LRN group Laparoscopic radical nephrectomy 39 patients with high complexity renal tumors who underwent laparoscopic radical nephrectomy
- Primary Outcome Measures
Name Time Method Postoperative complication up to 3 months postoperatively abnormal problmes that may be seen after surgery and require additional intervention, treatment or follow-up
functional outcomes 1 year after the surgery serum creatinine level (mg /dL) and estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2)
surigcal margin status postoperative follow-up, through study completion, an average of 1 year presence or absence of tumors at the surgical margin
CKD stage upgrading postoperative follow-up, through study completion, an average of 1 year evaluation of preoperative and postoperative renal functions according to chronic kidney disease stages
Oncological outomes postoperative follow-up, through study completion, an average of 1 year Presence or absence of local and/or distal tumor recurrence
Operation time at the end of the surgery time from onset to complete of surgery
Blood loss at the end of the surgery amount of bleeding during surgery (mL)
warm ischemia time at the and of the surgery The clamp time of the renal artery and vein which is required to complete tumor excision and renorrhaphy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ondokuz Mayıs University, Department of Urology
🇹🇷Samsun, Turkey